Neuron23
Combining cutting-edge science, human genetics, and a patient-centered approach to transform how we treat Parkinson’s.
28 employees · est. 2018 · South San Francisco, United...
T3D Therapeutics, Inc.
Developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegenerative diseases.
12 employees · est. 2013 · Durham, United States
T3D Therapeutics, Inc. is the older company (2018 vs 2013).
Side-by-Side Comparison
| Metric | Neuron23 | T3D Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2013 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Durham, United States |
| Employees | ||
| Employees | 28 | 12 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series D | Series Unknown |
| Total Funding | ||
| Total Funding | $230.00M | $40.31M |
| Funding Rounds | ||
| Funding Rounds | 4 | 8 |
| Services | ||
| Services | Development of precision medicine for Parkinson's Disease, Clinical trials for novel therapeutic approaches, Research and development in neuroimmunology and neuroscience | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Parkinson's Disease, Healthcare providers specializing in neurology, Pharmaceutical and biotechnology investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Medicine, Parkinson's Disease, Neurodegenerative Diseases, Human Genetics, Biomarker Platform, Drug Discovery, Neurological Diseases, Alzheimer's Disease, Clinical-stage Biotechnology, Hyperactive LRRK2, Patient-centered Approach, Neuroinflammatory Diseases, Autoimmune Diseases | Alzheimer's Disease, Neurodegenerative Diseases, Drug Development, T3D-959, Disease-modifying, Breakthrough Medicine, Clinical Studies, Huntington's Disease, Therapeutic Utility, Potential Treatment, Disease Reversal |
| Website | ||
| Website | neuron23.com | t3dtherapeutics.com |
About Neuron23
Neuron23, founded in 2018, is a clinical-stage biotechnology company based in the United States. The company is pioneering advancements in precision medicine, specifically targeting Parkinson’s disease driven by hyperactive LRRK2. By integrating cutting-edge science with human genetics and its propr...
About T3D Therapeutics, Inc.
T3D Therapeutics, Inc. is a biotechnology startup founded in 2013, based in the United States. The company is dedicated to developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegenerative diseases. Their lead drug product candidate, T3D-959, is positioned as...
We will tell you when either one moves
BounceWatch watches Neuron23 and T3D Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Neuron23 and T3D Therapeutics, Inc. — by email.
Frequently Asked Questions
Compare Neuron23 with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Neuron23 on 31 Mar 2026, and T3D Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.